Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Warren, New Jersey
- Most recent report
- 8-K, filed Nov 3, 2026
- Incorporated
- Delaware
- Filings on record
- 1,000+ filings
- On EDGAR
- CIK 1070081
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 39
News 8 of 137
Prospectuses and Registrations 8 of 25
- S-3ASR Automatic shelf registration May 5, 2023
- S-8 Registration statement for an employee plan Dec 16, 2022
- S-3ASR Automatic shelf registration Dec 16, 2022
- S-8 Registration statement for an employee plan Jun 23, 2022
- S-8 POS Post-effective amendment to an employee plan registration Apr 13, 2022
- S-8 Registration statement for an employee plan Jan 5, 2022
- S-8 Registration statement for an employee plan Jan 4, 2021
- 424B5 Prospectus supplement for an offering Aug 21, 2020
Proxies 8 of 21
- DEFA14A Extra proxy material Apr 20, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 20, 2026
- DEFA14A Extra proxy material Apr 30, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 30, 2025
- DEFA14A Extra proxy material Apr 26, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 26, 2024
- DEFA14A Extra proxy material Apr 26, 2023
- DEF 14A Proxy statement for a shareholder vote Apr 26, 2023
Ownership 8 of 744
- 4 Insider reported a trade Oct 16, 2026
- 4 Insider reported a trade Oct 13, 2026
- 4 Insider reported a trade Oct 9, 2026
- 144 Notice of a proposed sale of restricted stock Oct 9, 2026
- 4 Insider reported a trade Oct 7, 2026
- 144 Notice of a proposed sale of restricted stock Oct 7, 2026
- 144 Notice of a proposed sale of restricted stock Oct 6, 2026
- 144 Notice of a proposed sale of restricted stock Oct 5, 2026
Other 8 of 34
Everything here comes from Ptc Therapeutics, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.